Issues along the Potomac: "efficacy" and "technology transfer".
"Efficacy" and "technology transfer" are currently subjects of intense interest to health-related agencies in Washington. These jargon terms refer to assuring that useful knowledge is applied to all who need it and that the application of ineffective technology is discouraged. There is no public or private institution responsible for either assembling data on efficacy or for quaranteeing that necessary studies are undertaken. The determination of efficacy is important for cost control, quality assurance, planning, and any national health insurance plan. Whether engaged principally in practice, teaching, or research, it is important for physicians not only to be conversant with these issues but to participate in the resolution of the questions involved.
D003362:Cost-Benefit Analysis; D006801:Humans; D013677:Medical Laboratory Science / Q000191:economics; D009316:National Institutes of Health (U.S.); D011787:Quality of Health Care; D012106:Research; D014481:United States